Franklin Genomic Advancements ETF (HELX)

BATS: HELX · IEX Real-Time Price · USD
-0.01 (-0.02%)
Sep 29, 2023, 4:00 PM EDT - Market closed
Assets $8.50M
Expense Ratio 0.50%
PE Ratio 18.50
Shares Out n/a
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return -4.76%
Volume 150
Open 28.30
Previous Close 28.34
Day's Range 28.28 - 28.34
52-Week Low 28.09
52-Week High 32.75
Beta n/a
Holdings 59
Inception Date Feb 25, 2020

About HELX

Fund Home Page

The Franklin Genomic Advancements ETF (HELX) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. HELX was launched on Feb 25, 2020 and is issued by Franklin Templeton.

Asset Class Equity
Category Health
Region Global
Stock Exchange BATS
Ticker Symbol HELX
ETF Provider Franklin Templeton

Top 10 Holdings

43.35% of assets
Name Symbol Weight
Thermo Fisher Scientific Inc. TMO 6.21%
Danaher Corporation DHR 6.05%
Medpace Holdings, Inc. MEDP 5.62%
Repligen Corporation RGEN 5.14%
Vertex Pharmaceuticals Incorporated VRTX 4.27%
Regeneron Pharmaceuticals, Inc. REGN 4.14%
Sartorius AG Participating Preferred SRT3.DE 3.15%
Krystal Biotech, Inc. KRYS 3.02%
Samsung BioLogics Co Ltd 207940.KS 2.90%
Us Dollar n/a 2.85%
View More Holdings


Ex-Dividend Amount Pay Date
2021-12-30 $0.00394 2022-01-07
2021-12-13 $0.11415 2021-12-21
2020-12-14 $0.05178 2020-12-23
Full Dividend History


Hop on HELX for Potential Biotech M&A

Blame inflation and rising interest rates, among other factors, but biotechnology mergers and acquisitions activity remains lethargic. That's despite a slump in biotech stocks dating back to early 202...

1 year ago - ETF Trends

Invest in the Fully Mapped Human Genome With This ETF

Scientists have completed mapping the human genome. New research from the Telomere-to-Telomere (T2T) Consortium, a loose collaborative of about 100 scientists, shows that the team has completed a chal...

1 year ago - ETF Trends